Could a nasal spray of insulin and glutathione ease Parkinson's symptoms?
NCT ID NCT05266417
First seen Apr 06, 2026 · Last updated May 08, 2026 · Updated 6 times
Summary
This study tests whether a daily nasal spray containing insulin and glutathione can safely improve thinking and movement in people with Parkinson's disease. About 56 adults with Parkinson's will receive either the active spray or a placebo for several months, while continuing their usual medications. The goal is to see if this add-on therapy helps with verbal fluency and motor function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute for Neuroimmune Medicine
RECRUITINGDavie, Florida, 33314, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Las Mercedes Medical Research
RECRUITINGHialeah, Florida, 33012, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.